PetMed Express FY2025 net sales $227M, net loss $6.3M; Q1/Q2 filings delayed

PETMED EXPRESS INC

2026-Q2 EPS reported -$2.05 revenue$95,544,000

Net sales of $227.0M for FY2025 below preliminary range of $231.6M-$233.6M due to restatement of promotional sales reimbursements to cost of sales.
Net loss of $6.3M widened from preliminary estimated loss of $4.5M-$5.0M, driven by a $1.2M non-cash impairment charge for intangible assets.
Cash balance of $54.7M and no debt as of March 31, 2025.
Company filed Form 10-K; plans to file Q1 and Q2 2025 reports and resume normal quarterly earnings call cadence.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.